U.S., Feb. 8 -- ClinicalTrials.gov registry received information related to the study (NCT06814548) titled 'Immune Checkpoint Inhibitors (ICIs) Retreatment in Second-line Treatment of Advanced Gastric Cancer: a Retrospective, Real-world Study' on Feb. 03.
Brief Summary: This is a single-center, retrospective, observational, real-world study. We collected general and clinical data of patients with advanced gastric cancer who were admitted to the First Affiliated Hospital of Zhengzhou University from January 2018 to July 2024.
Study Start Date: Feb. 10
Study Type: OBSERVATIONAL
Condition:
Gastric Cancer, Gastroesophageal Junction Cancer
Immune Checkpoint Inhibitors (ICIs)
Second-line
Retreatment
Intervention:
OTHER: ICIs(Immune checkpo...